Hamel Associates, Inc. Abb Vie Inc. Transaction History

Hamel Associates, Inc.

$315 Million
Q2 2024

A detailed history of Hamel Associates, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hamel Associates, Inc. holds 20,555 shares of ABBV stock, worth $4.04 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

20,555

Previous 24,221 15.14%

Holding current value

$4.04 Million

Previous $4.41 Million 20.07%

% of portfolio

1.12%

Previous 1.41%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 02, 2024	SELL	$154.79 - $180.76 $567,460 - $662,666	-3,666 Reduced 15.14%	20,555 $3.53 Million
Q1 2024 Apr 23, 2024	SELL	$159.82 - $182.1 $475,464 - $541,747	-2,975 Reduced 10.94%	24,221 $4.41 Million
Q4 2023 Feb 08, 2024	SELL	$137.6 - $154.97 $30,960 - $34,868	-225 Reduced 0.82%	27,196 $4.21 Million
Q2 2023 Aug 08, 2023	SELL	$132.51 - $164.9 $29,814 - $37,102	-225 Reduced 0.81%	27,421 $3.69 Million
Q1 2023 May 08, 2023	SELL	$144.61 - $166.54 $9,399 - $10,825	-65 Reduced 0.23%	27,646 $4.41 Million
Q4 2022 Feb 06, 2023	SELL	$138.31 - $165.87 $34,577 - $41,467	-250 Reduced 0.89%	27,711 $4.48 Million
Q3 2022 Nov 09, 2022	SELL	$134.21 - $153.93 $40,263 - $46,179	-300 Reduced 1.06%	27,961 $3.75 Million
Q2 2022 Aug 08, 2022	SELL	$137.62 - $174.96 $34,405 - $43,740	-250 Reduced 0.88%	28,261 $4.33 Million
Q1 2022 May 06, 2022	SELL	$131.98 - $163.75 $527 - $655	-4 Reduced 0.01%	28,511 $4.62 Million
Q4 2021 Feb 08, 2022	BUY	$107.43 - $135.93 $5,371 - $6,796	50 Added 0.18%	28,515 $3.86 Million
Q3 2021 Nov 08, 2021	BUY	$106.4 - $120.78 $139,384 - $158,221	1,310 Added 4.82%	28,465 $3.07 Million
Q2 2021 Aug 04, 2021	BUY	$105.21 - $117.21 $1.39 Million - $1.55 Million	13,250 Added 95.29%	27,155 $3.06 Million
Q1 2021 May 04, 2021	BUY	$102.3 - $112.62 $1.42 Million - $1.57 Million	13,905 New	13,905 $1.51 Million
Q1 2018 May 03, 2018	SELL	$92.01 - $123.21 $197,821 - $264,901	-2,150 Closed	0 $0
Q4 2017 Feb 13, 2018	BUY	$89.56 - $98.21 $192,554 - $211,151	2,150	2,150 $208,000

Others Institutions Holding ABBV

# of Institutions

3,685

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $347B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamel Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hamel Associates, Inc. with notifications on news.

Account

Hamel Associates, Inc. Abb Vie Inc. Transaction History